Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

298 ARTÍCULOS , VIENDO DEL 196 AL 210

Neurotrophic factor therapy for Parkinson's disease

Rangasamy SB, Soderstrom K, Bakay RA, Kordower JH.

Prog Brain Res. 2010;184:237-64. doi: 10.1016/S0079-6123(10)84013-0.

Scales to assess sleep impairment in Parkinson's disease: critique and recommendations

Högl B, Arnulf I, Comella C, Ferreira J, Iranzo A, Tilley B, Trenkwalder C, Poewe W, Rascol O, Sampaio C, Stebbins GT, Schrag A, Goetz CG.

Mov Disord. 2010 Dec 15;25(16):2704-16. doi: 10.1002/mds.23190.

Molecular chaperones as rational drug targets for Parkinson's disease therapeutics

Kalia SK, Kalia LV, McLean PJ.

CNS Neurol Disord Drug Targets. 2010 Dec;9(6):741-53. doi: 10.2174/187152710793237386.

2-Hydroxy-3-isobutyl-9-[(11)C]methoxy-10-methoxy-1,2,3,4,6,7,-hexahydro-11bH-bezo[α]-quinolizine

Leung K.

2006 Mar 17 [updated 2010 Oct 27]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.

The MoCA: well-suited screen for cognitive impairment in Parkinson disease

Dalrymple-Alford JC, MacAskill MR, Nakas CT, Livingston L, Graham C, Crucian GP, Melzer TR, Kirwan J, Keenan R, Wells S, Porter RJ, Watts R, Anderson TJ.

Neurology. 2010 Nov 9;75(19):1717-25. doi: 10.1212/WNL.0b013e3181fc29c9.

Development of Parkinson's disease biomarkers

Prakash KM, Tan EK.

Expert Rev Neurother. 2010 Dec;10(12):1811-25. doi: 10.1586/ern.10.73.

Tic Disorder: An Unusual Presentation of Neurotoxoplasmosis in a Patient with AIDS

Aquino CC, Felício AC, Godeiro-Junior C, Santos-Neto D, Pedroso JL, Oliveira AS, Silva SM, Borges V, Ferraz HB.

Case Rep Neurol. 2010 Nov 15;2(3):145-149. doi: 10.1159/000322185.

α-Synuclein and DJ-1 as potential biological fluid biomarkers for Parkinson's Disease

Waragai M, Sekiyama K, Sekigawa A, Takamatsu Y, Fujita M, Hashimoto M.

Int J Mol Sci. 2010 Oct 29;11(11):4257-66. doi: 10.3390/ijms11114257.

[Transcranial sonography in diagnosis of movement disorders]

Ambrosius W, Kozubski W.

Neurol Neurochir Pol. 2010 Nov-Dec;44(6):574-9. doi: 10.1016/s0028-3843(14)60155-9.

[Orthostatic tremor causing postural instability in Parkinson disease: report of one case]

Aguilar E, Pollak D, Necochea C, Fadic R, Juri C.

Rev Med Chil. 2010 Nov;138(11):1410-3. Epub 2011 Jan 27.

Identification of a small molecule that selectively inhibits alpha-synuclein translational expression

Ross NT, Metkar SR, Le H, Burbank J, Cahill C, Germain A, MacPherson L, Bittker J, Palmer M, Rogers J, Schreiber SL.

2011 Feb 10 [updated 2011 Feb 15]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010–.

Identification of a small molecule that selectively activates alpha-synuclein translational expression

Ross NT, Metkar SR, Le H, Burbank J, Cahill C, Germain A, MacPherson L, Bittker J, Palmer M, Rogers J, Schreiber SL.

2011 Feb 4 [updated 2011 Feb 15]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010–.

Involuntary movements during vitamin B12 treatment

Ozdemir O, Baytan B, Gunes AM, Okan M.

J Child Neurol. 2010 Feb;25(2):227-30. doi: 10.1177/0883073809333528. Epub 2009 Jun 12.

[Sleep paroxysmal events in children in video/polysomnography]

Zajac A, Skowronek-Bała B, Wesołowska E, Kaciński M.

Przegl Lek. 2010;67(9):762-9.

Neurological sequelae of hypoxic-ischemic brain injury

Lu-Emerson C, Khot S.

NeuroRehabilitation. 2010;26(1):35-45. doi: 10.3233/NRE-2010-0534.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias